VORSCHAU

PRESSETERMINE

AKTUELLES PRESSEFOTO



WETTER
Graz: bedeckt
24°
Innsbruck: Regen
22°
Linz: Regen
22°
Wien: bedeckt
20°
© wetter.net

Stadtname / PLZ

AKTIENKURSE
 
ADHOC
Mi, 23.02.2022 21:15
Meldung drucken Artikel weiterleiten
pta20220223075
Public disclosure of inside information according to article 17 MAR
Pressefach Pressefach

capsensixx AG: Preliminary results for 2021 exceed earnings forecast

Frankfurt am Main (pta075/23.02.2022/21:15) - Preliminary results for 2021 exceed earnings forecast

• Earnings after taxes (without non controlling interests) 2021: EUR 3.0 million (2020: EUR 2.3 million)

• DVFA eps per share 2021: EUR 0.94 (2020: EUR 0.66)

Frankfurt am Main, February 23rd, 2022

According to preliminary figures, capsensixx closed the 2021 financial year - which was characterized by high uncertainties due to COVID-19 - with a result for 2021 that was above the annual forecast.

The following key figures for 2020 and 2021 are given before deduction of third-party shares, unless otherwise indicated.

In 2021, net commission income increased by 9.8 % to EUR 26.5 million (2020: EUR 24.2 million).

The result after taxes (without non controlling interests) is reported at EUR 3.0 million (2020: EUR 2.3 million) in the 2021 financial year. The DVFA eps are reported at EUR 0.94 (2020: EUR 0.66).

With these preliminary results for the 2021 financial year, the forecast for the 2021 financial year made in the first half of 2021 was exceeded. The positive earnings trend continued in the second half of 2021.

The annual report 2021 of capsensixx - as published in the financial calendar - will be available from April 27, 2022 at www.capsensixx.de.

(Ende)

Aussender: capsensixx AG
Bettinastraße 57-59
60325 Frankfurt am Main
Deutschland
Ansprechpartner: Martin Stuerner
Tel.: +49 69 7680585-25
E-Mail:
Website: www.capsensixx.de
ISIN(s): DE000A2G9M17 (share)
Börsen: regulated market in Frankfurt; free market in Dusseldorf, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
capsensixx AG
   
Wie fanden Sie diese Meldung?
Weitersagen
likes dislike Share Share |
Social Media
ETARGET

FOCUSTHEMA


SPECIALS


Werbung
middleAdvertising